The 1st Annual "Top Pharmaceutical Patient Advocacy Teams" As Rated by Patient Advocates

News provided by

The Advocate: Supporting the Patient Voice

Jul 11, 2022, 08:33 ET

MOUNT PLEASANT, S.C., July 11, 2022 /PRNewswire/ -- The Advocate: Supporting the Patient Voice is excited to announce the first ever Top Overall Pharmaceutical Patient Advocacy Organizations. The Advocate's mission is to keep the patient at the center of all healthcare decision making by elevating the voice of the patient's loudest supporters, the patient advocacy organizations (PAOs). The Advocate elevates the voice of the Patient Advocate to the pharmaceutical manufacturers who aim to work "hand-in-hand" with PAOs to drive better patient outcomes. With their latest syndicated report, The Advocate provides this new metric eagerly desired by its subscribers. The ranking was completed by assigning point values for placing within the top 5 for each of the 5 stack-ranked categories—a feat that requires intense commitment by the pharmaceutical advocacy teams on its own. The Advocate then pooled the total points earned by each organization to generate the overall scores shown below:

The Advocate, working together with patient advocacy, professional associations/societies and pharmaceutical companies, hand-in-hand.
The Advocate, working together with patient advocacy, professional associations/societies and pharmaceutical companies, hand-in-hand.
The top pharmaceutical patient advocacy organizations for 2021/2022 as rated by our syndicated research respondents
The top pharmaceutical patient advocacy organizations for 2021/2022 as rated by our syndicated research respondents
The Advocate, working together with patient advocacy, professional associations/societies and pharmaceutical companies, hand-in-hand. The top pharmaceutical patient advocacy organizations for 2021/2022 as rated by our syndicated research respondents

In first place with a cumulative score of 23 out of a total 25 points is Janssen, The Pharmaceutical Companies of Johnson & Johnson, followed closely by Bristol Myers Squibb with 16 overall points and Pfizer rounding out the top 3 with 12 points.

It's important to note, each of the organizations included in the list above won at least one top 5 ranking in each of The Advocate's five key categories. That in itself is a huge accomplishment for these organizations.

However, The Advocate Notes, "we acclaim our top three overall Pharmaceutical Advocacy Teams and commend runners up, Amgen in 4th overall with 11 points, Eli Lilly in 5th with 7 points, Merck in 6th with 5 points and AstraZeneca, Sanofi & AbbVie rounding out the rankings with 1 point each. This was a great year for all organizations involved and we look forward to bringing forth this metric in future years," noted Matt Toresco, Editor-in-Chief of the syndicated market research program.

The Advocate would like to congratulate each of these organizations for the great feedback they received from the respondents in the 2021/2022 data set fielded by The Advocate Supporting the Patient Voice in the United States. Matt Toresco has noted that The Advocate is currently fielding its ex-US report in Canada, Latin America, Asia & Europe & his organization looks forward to providing the first ever EX-US Top Overall Pharmaceutical Patient Advocacy Organizations in a few months.

Feel free to reach out to The Advocate with any questions about their data or if you would like to discuss how they developed their overall findings. You can reach out to the team at The Advocate at [email protected] or through their website at https://theadvocatepatientvoice.com.

SOURCE The Advocate: Supporting the Patient Voice